Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing ...

Seeks ideas for investing fiscal year 2026 opioid settlement funds The Wisconsin Department of Health Services (DHS) awarded agencies in communities across the state more than $21 million from the ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...

Teva might be known for its sandals, but its new Trailwinder Hiking Shoe was great for dry land trail excursions. The post ...

Deep into Brooklyn by Gravesend, behind a trio of what seem to be nondescript gated doors, is a treasure of a kosher ...

Oppenheimer raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $31 from $29 and keeps an Outperform rating on the shares.

Samsung Bioepis Co. and Teva Pharmaceutical Industries (TEVA have entered into a license, development and commercialization agreement ...

A Trump transition savant is helping to guide Robert F. Kennedy Jr. — President-elect Donald Trump’s controversial pick to ...

Under the terms of the agreement, Samsung Bioepis will be responsible for the development, regulatory registration, ...